Literature DB >> 6085392

Cellular protein and RNA antigens in autoimmune disease.

R M Bernstein, C C Bunn, G R Hughes, A M Francoeur, M B Mathews.   

Abstract

Antibodies directed against soluble cellular antigens are a distinctive feature of systemic autoimmune disease. We have examined 22 autoantibodies in sera from 1111 patients and present the disease associations together with a biochemical analysis of the antigens. The data emphasize the clinical specificity of the antibodies and the restricted number of cellular components that commonly elicit an immune response. In several instances, serological relationships between antibodies mirror biochemical relationships between the corresponding antigens. The antigens are mainly proteins and are often present in complexes with additional protein or nucleic acid molecules. In myositis the antibodies react chiefly with cytoplasmic antigens such as aminoacyl-tRNA synthetases, in contrast to the mainly antinuclear response in SLE. It is argued that both environmental stimuli and genetic factors govern autoantibody specificity, and that molecular characterization of the cellular antigens may yield clues to the aetiology of the disease and of the concomitant, specific autoimmune response.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085392

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  27 in total

1.  Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen.

Authors:  Q Ge; M B Frank; C O'Brien; I N Targoff
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Antibody to a 63 kilodalton insect protein in ankylosing spondylitis.

Authors:  S R Brand; J Worthington; D P McIntosh; R M Bernstein
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

3.  A human monoclonal autoantibody to a nucleolar structure.

Authors:  M F Gonzalez; I Wichmann; J Yelamos; J Melero; R Magariño; J Sanchez-Roman; A Nuñez-Roldan; B Sanchez
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

4.  Identification of protein components reactive with anti-PM/Scl autoantibodies.

Authors:  C Gelpi; A Algueró; M Angeles Martinez; S Vidal; C Juarez; J L Rodriguez-Sanchez
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

Review 5.  Systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

6.  Anti-SM and anti-U1-RNP lupus antibody fine specificities.

Authors:  A M Francoeur
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

7.  Autoantibodies to purified nuclear proteins related to DNA metabolism during ageing and in SLE patients.

Authors:  G C Astaldi Ricotti; M Pazzaglia; A M Martelli; A Cerino; M Bestagno; A Caprelli; S Riva; M A Pedrini; A Facchini
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

8.  Lupus/Sjögren's autoantibody specificities in sera with paraproteins.

Authors:  A L Sestak; J B Harley; S Yoshida; M Reichlin
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

9.  Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.

Authors:  Hideo Yoshida; Minoru Satoh; Krista M Behney; Chee-Gun Lee; Hanno B Richards; Victoria M Shaheen; Jun-Qi Yang; Ram R Singh; Westley H Reeves
Journal:  Arthritis Rheum       Date:  2002-08

10.  Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion.

Authors:  C Gelpi; E J Sontheimer; J L Rodriguez-Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.